191 related articles for article (PubMed ID: 14739042)
1. Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer.
Urruticoechea A; Mesía R; Domínguez J; Falo C; Escalante E; Montes A; Sancho C; Cardenal F; Majem M; Germà JR
Lung Cancer; 2004 Feb; 43(2):209-14. PubMed ID: 14739042
[TBL] [Abstract][Full Text] [Related]
2. [Observation of endovascular stent insertion for non-small cell lung cancer patients with superior vena cava syndrome].
Li F; Sun X; Liang S; Jiang S; Mao L
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):47-51. PubMed ID: 25877319
[TBL] [Abstract][Full Text] [Related]
3. Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancer.
Calsina Juscafresa L; Gil Bazo I; Grochowicz L; Páramo Alfaro M; López-Picazo González JM; Moreno Jiménez M; Bilbao Jaureguizar JI
Hosp Pract (1995); 2017 Aug; 45(3):70-75. PubMed ID: 28618844
[TBL] [Abstract][Full Text] [Related]
4. [Stenting for superior vena cava obstruction associated with lung cancer: monocentric study].
Pierre MC; Chabbert V; Lozano S; Bigay-Game L; Lévêque N; Desloques L; Otal P; Rousseau H; Didier A; Mazières J
Rev Mal Respir; 2009 Sep; 26(7):744-50. PubMed ID: 19953016
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous stenting of superior vena cava syndrome: treatment outcome in patients with benign and malignant etiology.
Barshes NR; Annambhotla S; El Sayed HF; Huynh TT; Kougias P; Dardik A; Lin PH
Vascular; 2007; 15(5):314-21. PubMed ID: 17976332
[TBL] [Abstract][Full Text] [Related]
6. A retrospective stenting study on superior vena cava syndrome caused by lung cancer.
Wei S; Liu J; Li X; Song Z; Dong M; Zhao H; Zhao Q; Chen G; Chen J
Thorac Cancer; 2020 Jul; 11(7):1835-1839. PubMed ID: 32438532
[TBL] [Abstract][Full Text] [Related]
7. Use of self-expanding vascular endoprostheses in superior vena cava syndrome.
García Mónaco R; Bertoni H; Pallota G; Lastiri R; Varela M; Beveraggi EM; Vassallo BC
Eur J Cardiothorac Surg; 2003 Aug; 24(2):208-11. PubMed ID: 12895609
[TBL] [Abstract][Full Text] [Related]
8. Superior vena cava syndrome.
Wudel LJ; Nesbitt JC
Curr Treat Options Oncol; 2001 Feb; 2(1):77-91. PubMed ID: 12057143
[TBL] [Abstract][Full Text] [Related]
9. Endovascular stenting for end-stage lung cancer patients with superior vena cava syndrome post first-line treatments - A single-center experience and literature review.
Kuo TT; Chen PL; Shih CC; Chen IM
J Chin Med Assoc; 2017 Aug; 80(8):482-486. PubMed ID: 28501315
[TBL] [Abstract][Full Text] [Related]
10. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
Leung ST; Sung TH; Wan AY; Leung KW; Kan WK
Hong Kong Med J; 2015 Oct; 21(5):426-34. PubMed ID: 26139689
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of endovascular prostheses as initial treatment for superior vena cava syndrome of malignant cause].
Talens A; Ferrer S; González-Cruz A; Blanco E; García-Ferrer L; Iranzo V; Camps C
Med Clin (Barc); 2013 Jan; 140(2):59-65. PubMed ID: 22237043
[TBL] [Abstract][Full Text] [Related]
12. Malignant obstruction of superior vena cava: Endovascular stenting using Y-configuration stent in stent technique.
Noor Khairiah AK; Mohamad Nazrulhisham MN; Hazman MN
Med J Malaysia; 2018 Dec; 73(6):407-409. PubMed ID: 30647215
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous Endovascular Stent Placement for Treatment of Malignant Superior Vena Cava Syndrome: A Retrospective Review.
Wu Y; Li Y; Wang M; Li W; Qiu X
Ann Vasc Surg; 2022 Mar; 80():325-332. PubMed ID: 34780937
[TBL] [Abstract][Full Text] [Related]
14. The role of self-expanding vascular stent in superior vena cava syndrome for advanced tumours.
Irace L; Martinelli O; Gattuso R; Mingoli A; Fiori E; Alunno A; Di Girolamo A; Crocetti D; Sapienza P
Ann R Coll Surg Engl; 2021 Apr; 103(4):296-301. PubMed ID: 33682470
[TBL] [Abstract][Full Text] [Related]
15. A new nitinol stent for use in superior vena cava syndrome. Initial clinical experience.
Andersen PE; Midtgaard A; Brenøe AS; Elle B; Duvnjak S
J Cardiovasc Surg (Torino); 2015 Dec; 56(6):877-81. PubMed ID: 26212865
[TBL] [Abstract][Full Text] [Related]
16. Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy.
Fagedet D; Thony F; Timsit JF; Rodiere M; Monnin-Bares V; Ferretti GR; Vesin A; Moro-Sibilot D
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):140-9. PubMed ID: 22146975
[TBL] [Abstract][Full Text] [Related]
17. Vascular stenting for palliation of superior vena cava obstruction in non-small-cell lung cancer patients: a future 'standard' procedure?
Greillier L; Barlési F; Doddoli C; Durieux O; Torre JP; Gimenez C; Kleisbauer JP
Respiration; 2004; 71(2):178-83. PubMed ID: 15031575
[TBL] [Abstract][Full Text] [Related]
18. [Use of an expandable metallic stent in 4 patients with superior vena syndrome].
Kotani K; Asai T; Fujita K; Tanizaki M; Higashi R
Kyobu Geka; 1999 Dec; 52(13):1109-11. PubMed ID: 10589191
[TBL] [Abstract][Full Text] [Related]
19. Stent Implantation for Superior Vena Cava Syndrome of Malignant Cause.
Büstgens FA; Loose R; Ficker JH; Wucherer M; Uder M; Adamus R
Rofo; 2017 May; 189(5):423-430. PubMed ID: 28152555
[No Abstract] [Full Text] [Related]
20. Stenting and superior vena caval syndrome.
Wilkinson P; MacMahon J; Johnston L
Ir J Med Sci; 1995; 164(2):128-31. PubMed ID: 7541784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
